Replies to post #97291 on Kraig Biocraft Laboratories Inc (KBLB)

[Eskaminagaga]

You bring up an interesting point. This is a good way to value Spiber Inc. and compare it to KBLB.

The $30 mil over 1.88 million shares is $15.96 a share. The 1.88 million shares is only about 12% of the company, so that puts their assumed value at about $250 million.

KBLB is currently at 3 cents a share over 681,579,159 shares per the last filing leaving only a $20,447,374.77 value. Less than a tenth the value of Spiber Inc.

If we were to have the same value as Spiber Inc., the share price would have to be about 36 cents a share. Of course, this is a pre-commercialization value, so it is likely to go up more after they start selling some silk.

IMO, this shows that KBLB is significantly undervalued and should expect high growth in pps post-commercialization.